Nutrien Completes Sale of Equity Position in Profertil S.A.

Executive Summary

• Nutrien completed the sale of its 50 % equity stake in Argentina‑based nitrogen producer Profertil S.A. for approximately US $600 million (pre‑tax).
• The proceeds are earmarked for capital allocation priorities, including growth investments, share repurchases and debt reduction.
• With this transaction, total gross proceeds from asset divestitures since Q4 2024 now approximate US $900 million.

Key Details

• Transaction: Sale of 50 % equity position in Profertil S.A. to Adecoagro S.A. and Asociacion de Cooperativas Argentinas Coop Ltda (joint acquisition).
• Consideration: Approximately US $600 million on a pre‑tax basis.
• Use of Proceeds: Targeted growth investments, share repurchases, and debt reduction to enhance free cash flow per share.
• Cumulative Divestiture Proceeds: Approx. US $900 million gross proceeds from asset sales since Q4 2024.
• Strategic Rationale: Simplify portfolio, improve earnings quality, and boost cash conversion.

Notable Quotes

“Closing the sale of our equity stake in Profertil demonstrates continued progress towards simplifying our portfolio, enhancing earnings quality, and improving cash conversion,” said Ken Seitz, Nutrien’s President and CEO.
“We intend to allocate the proceeds towards capital allocation priorities that support our ability to grow free cash flow per share over the long term, including targeted growth investments, share repurchases and debt reduction.”